Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions
Journal of Drugs in Dermatology · 01.04.2026 · 25 (4) · 311-315
DOI: 10.36849/jdd.9613 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.03.2026. Verfasst von Joshua Burshtein und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Chronic Urticaria, Protein Kinase Inhibitors, Pyrimidines. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Burshtein, J., & Schlesinger, T. (2026). Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions. Journal of Drugs in Dermatology, 25(4), 311-315. https://doi.org/10.36849/jdd.9613
Vancouver
Burshtein J, Schlesinger T. Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions. Journal of Drugs in Dermatology. 2026;25(4):311-315. doi:10.36849/jdd.9613
BibTeX
@article{Burshtein2026,
author = {Burshtein, Joshua and Schlesinger, Todd},
title = {Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {4},
pages = {311--315},
doi = {10.36849/jdd.9613}
}
EUVIMED